
Video Channels

FEATURED VIDEOS
What is Ocular Melanoma?
Through The Lens Of An Ocular Oncologist: What is Ocular Melanoma?


Through The Lens Of An Ocular Oncologist: What is Ocular Melanoma?

Uveal Melanoma with Liver Metastases: Patient Experience, Treatment Challenges & Hope on the Horizon

Uveal Melanoma 2022 | C. Shields

Uveal Melanoma, A Modern Approach to Ocular Oncology | Tara McCannel, MD | UCLAMDChat

Choroidal Melanoma

Ocular Melanoma - See Your Eye Professional Today


FEATURED CHANNELS


Can cancer treatment impact my eyes and vision?
Many cancer treatments can affect your eyes and vision in a variety of ways. Some mild eye-related side effects, such as dryness or blurred vision, can resolve on their own, but serious side effects can impact your vision in the long term.

American Society of Retina Specialists
Diabetic Eye Disease Awareness Month 2025: Early intervention can prevent vision loss


Diabetic Eye Disease Awareness Month 2025: Early intervention can prevent vision loss

Diabetic Eye Disease Awareness Month: Bringing extraordinary skill and dedication to complex care.

Diabetic Eye Disease Awareness Month: Specialized Retina Care Saves Sight

The mission of The Eye Cancer Foundation is three-fold: to develop and encourage international, multi-center research on new diagnostic treatments; to provide much-needed support services for patients and their families; and to save lives through our international fellowship program by training doctors in underserved and unserved countries.
It has been our goal to create a world-class resource for patients and their families diagnosed with eye cancer in the form of ocular tumors, macular degeneration, and related ophthalmic conditions. We want to help you, your children and families around the world.
The Eye Cancer Foundation
2023 ISOO Fellow Presentations: Day 3


2023 ISOO Fellow Presentations: Day 3

2023 ISOO Fellow Presentations: Day 2

2023 ISOO Fellow Presentations: Day 1

Finding Your Way With Ocular Melanoma
Vision Loss in Ocular Melanoma


Vision Loss in Ocular Melanoma

Navigating Ocular Melanoma - Group Support Program January 2026

Why Your Voice Matters: How Patients (Not Doctors) Move the Needle in MedicalProgress

The Melanoma Research Alliance
Advancing Discoveries,
Changing Lives, Curing Melanoma.
MRA is the world’s largest private nonprofit funder of melanoma research.
We’ve directly invested over $175 million toward scientific discoveries,
and we won’t stop until we achieve our mission of curing melanoma.
MelanomaReAlli
MRA Meet Up: Acral Melanoma Research Update


MRA Meet Up: Acral Melanoma Research Update

Outrun Melanoma: Leah Adams’ 31-Mile Mission

MRA Meet Ups: Unlocking LAG-3 – New Frontiers in Combination Immunotherapy for Melanoma

CURE OM (the Community United for Research and Education of Ocular Melanoma) is the MRF’s initiative to increase awareness, education and research funding for ocular melanoma, while improving the lives of people affected by this disease. Founded in 2011, the CURE OM initiative excels because of the hard work and dedication of its Patient and Scientific Steering Committees and the generosity of our community.
Cure Melanoma
Ask The Expert: Minimal Residual Disease Testing in Melanoma Management


Ask The Expert: Minimal Residual Disease Testing in Melanoma Management

A Message from Research Awardee, Craig Ceol, PhD on Research to Overcome Immunotherapy Resistance

2025 MRF New York Gala Courage Award

Ocular Melanoma
Last updated: 8/20/2024
Years published: 2018, 2024
Full Report Link @ https://rarediseases.org/rare-diseases/ocular-melanoma/
Acknowledgment
NORD gratefully acknowledges Gioconda Alyea, MD (FMG), MS, National Organization for Rare Disorders, Prithvi Mruthyunjaya, MD, MHS, Associate Professor of Ophthalmology, Ocular Oncology and Vitreoretinal Surgery; Director, Ocular Oncology Service, Byers Eye Institute at Stanford, and the Ocular Melanoma Foundation, for assistance in the preparation of this report.
Disease Overview
Summary
Ocular melanoma is an extremely rare type of cancer that occurs in about 5 out of every million adults. Despite its rarity, it is the most common primary cancer of the eye in adults. A primary cancer means that the cancer begins in the eye itself and has not spread there from another part of the body. The exact cause of ocular melanoma is unknown, but several risk factors have been identified, including genetic factors and possibly environmental influences. Despite this uncertainty, early detection and treatment are crucial for the best outcomes.
Introduction
Eye (ocular) cancer can refer to any cancer that starts in the eye.
The eye is a complex organ with three main parts:
-
Eyeball (globe): The main part of the eye, filled with a jelly-like substance called vitreous humor. It has three layers:
-
Sclera: The tough, white outer layer
-
Uvea: The middle layer, responsible for nourishment and containing the eye’s pigmented cells
-
Retina: The innermost layer, which senses light and is crucial for vision
-
-
Orbit: The tissues surrounding the eyeball
-
Adnexal structures: These include accessory parts like the eyelids and tear glands
Different types of cancer can develop in these areas depending on the type of cells involved. Ocular melanoma typically arises from cells called melanocytes, which produce pigment. When these melanocytes in the choroid become cancerous, the condition is known as choroidal or uveal melanoma. Although these melanocytes are similar to those in the skin, skin melanoma and ocular melanoma are distinct conditions, each with different biological and genetic characteristics. It is rare for skin melanoma to spread to the eye or vice versa.
Uveal melanomas
Ocular melanoma can start at the uveal tract, the colored layer of tissue beneath the white of the eye (sclera). The uvea consists of three parts:
-
Iris: The colored part of the eye which surrounds the pupil
-
Ciliary body: A ring of muscle tissue that releases aqueous humor (a clear fluid) and helps control the lens’s shape for focusing
-
Choroid: The largest part of the uveal tract, located at the back of the eye beneath the retina. This area is rich in blood vessels and pigmented cells.
Most ocular melanomas develop in the choroid or ciliary body. About 9 out of 10 intraocular melanomas occur in these areas. Iris melanomas are less common and usually easier to detect because they often start as a dark spot on the iris that grows over time. Iris melanomas are generally slow-growing and rarely spread, leading to a relatively good prognosis.
Uveal melanomas can spread through the bloodstream, most often reaching the liver, where the cancer can become life-threatening.
Conjunctival melanomas
The conjunctiva is a thin, clear layer covering the sclera. Conjunctival melanomas are extremely rare but tend to be more aggressive. They can grow into nearby structures and spread through both the blood and lymphatic systems, reaching distant organs like the lungs, liver or brain.
Full Report Link @ https://rarediseases.org/rare-diseases/ocular-melanoma/
National Organization for Rare Disorders (NORD)
Stay Covered: Open Enrollment Essentials for Rare Disease Families


Stay Covered: Open Enrollment Essentials for Rare Disease Families

From Voices to Breakthroughs: The 2025 NORD Breakthrough Summit

Hear from NORD Summit 2025 attendees: From Voices to Breakthroughs

OIS has set the benchmark for excellence in eye care innovation by uniting pioneering startups, leading strategics, top investors, and renowned clinicians. More than a conference, OIS is a trusted community where ideas take root, partnerships are born, and the future of ophthalmology is shaped. With expertly curated programming, exclusive networking opportunities, and unmatched access to breakthrough technologies, OIS empowers industry leaders to make impactful decisions and build relationships that last.
OIS: Ophthalmology Innovation Source
Blind Child Safety Reimagining the White Cane for Mobility


Blind Child Safety Reimagining the White Cane for Mobility

Blindness Revolutionizing Mobility and Changing Perceptions

OIS Pod Ep #423: Creating An Easier To Navigate World For Children

Ocular Melanoma Foundation is raising funds, engaging academicians and clinicians, and actively partnering with foundations and other leading agencies supporting cancer research to:
1. Support and accelerate scientific research and discovery and its translation into effective treatment options for patients.
2. Provide resources for education and support to OM patients, their families, and to healthcare professionals treating OM.
3. Act as an advocate within the melanoma and broader cancer community to raise the awareness of OM and the need for a cure.
Ocular Melanoma Foundation
Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong


Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong

Overview of Melanoma Gene Expression Profile (GEP) Test by Castle Biosciences

Patient Q&A with Ocular Melanoma Experts, Dr. Damato, Hovland, Mruthyunjaya, Seider
2017 Eye Am Not Alone
Patient & Caregiver Conference
Hosted by Ocular Melanoma Foundation
2017 OMF EANA Patient & Caregiver Conference
Experience Battling Ocular Melanoma as a Patient and a Mother


Experience Battling Ocular Melanoma as a Patient and a Mother

Clinical Trials for Ocular Melanoma, Discussion with Drs. Mruthyunjaya, Dr. Patel, and Dr. Stecher

Overview of Uveal Melanoma, Dr. Prithvi Mruthyunjaya

The Rare Cancer Alliance
Accelerating Cures Through
Patient-Powered Collaboration
MRA is the world’s largest private nonprofit funder of melanoma research.
We’ve directly invested over $175 million toward scientific discoveries,
and we won’t stop until we achieve our mission of curing melanoma.
Rare Cancer Research Foundation
Pattern.org Walkthrough


Pattern.org Walkthrough

Dr. Jesse Boehm Discusses Importance of Rare Cancer Tissue Donation Through Pattern.org

Accelerating Cancer Research: An Overview of The Rare Cancer Research Foundation

ENTERTAINMENT. Beyond Mishawaka.
















































